PSI Paul Scherrer Institut’s Post

View organization page for PSI Paul Scherrer Institut, graphic

31,803 followers

Researchers from PSI Paul Scherrer Institut, ETH Zürich and University of Geneva have revealed how drug molecules bind in a type of channel that connects neighbouring cells, changing intercellular communication. The team studied channels made from proteins called connexins, which allow small molecules and ions to be exchanged between adjacent cells. Dysfunctions of these channels has been linked to many different diseases including cardiac #arrhythmias, #epilepsy and #cancer. Using cryo-electron microscopy, the team revealed how the antimalarial drug, mefloquine, binds in the channels. As well as giving a possible explanation for well-known side effects of mefloquine, the research gives new understanding of how drug molecules act on connexins channels in general, aiding the development of connexin-targeting drugs. Full Story: https://lnkd.in/dKS7T6qh CC: Volodymyr Korkhov Image: Laura Canil #ResearchAtPSI #HealthInnovation #Neuroscience #DrugDiscovery #ResearchMatters

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics